AxoGen (AXGN) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | -16.4% | -16.9% | -8.38% | 3.24% | 0.09% | 2.39% | |
| Changes by years, y/y, % | +1pp | -1pp | +9pp | +12pp | -3pp | |||
AxoGen. EBITDA margin, %
AxoGen. EBITDA margin, changes, pp
AxoGen (AXGN) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 0.61% | 7.72% | 21.1% | -14.2% | -4.61% | 2.39% | |
| Changes by years, y/y, % | +6pp | +3pp | +17pp | -23pp | -5pp | |||
| Changes by quarters, q/q, % | -8pp | +7pp | +13pp | -35pp | +10pp | |||